Drug
Anacetrapib clinical trials
Also written MK-0859.
- studies test it
- 14
- open now
- 0
- in phase 3
- 8
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Development codes
- MK-0859
- 11
Studies by the year they started
14 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses anacetrapib is read from its arms, and is right about nine times in ten.
Testing it · 14
- REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modificationActive, not recruitingPhase 3University of OxfordNCT01252953Written as Anacetrapib
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)CompletedPhase 3Merck Sharp & Dohme LLCNCT01860729Written as Anacetrapib
- Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)CompletedPhase 3Merck Sharp & Dohme LLCNCT01524289Written as Anacetrapib
- Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)CompletedPhase 3Merck Sharp & Dohme LLCNCT00685776Written as anacetrapib
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)CompletedPhase 3Merck Sharp & Dohme LLCNCT01760460Written as Anacetrapib
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)CompletedPhase 3Merck Sharp & Dohme LLCNCT01717300Written as Anacetrapib 100 mg
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)CompletedPhase 3Merck Sharp & Dohme LLCNCT01824238Written as Anacetrapib
- Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)CompletedPhase 1Merck Sharp & Dohme LLCNCT01114490Written as anacetrapib
- Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)CompletedPhase 1Merck Sharp & Dohme LLCNCT01122667Written as anacetrapib
- Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)TerminatedPhase 3Merck Sharp & Dohme LLCNCT01841684Written as Anacetrapib
- A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)CompletedPhase 2Merck Sharp & Dohme LLCNCT00977288Written as anacetrapib
- MK0859 Dose-Ranging Study (0859-003)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00325455Written as MK0859
- A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00565006Written as MK0859
- A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00565292Written as MK0859
Given in every arm · 1 — anacetrapib is usual care beside what is tested
Codes
What other systems call anacetrapib · ClinicalTrials.gg INT005302
- MeSH (NLM) C530884anacetrapibConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P7T269PR6SANACETRAPIBConfirmed FDA, NLM, Wikidata
- Wikidata Q4750639anacetrapibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75251AnacetrapibOne source FDA
- DrugBank DB06630One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C530884 | anacetrapib | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P7T269PR6S | ANACETRAPIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4750639 | anacetrapib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75251 | Anacetrapib | One source FDA |
| DrugBank | DB06630 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.